| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/24/2006 | CN1256938C Cosmetics |
| 05/24/2006 | CN1256936C Skin care compositions containing osamine |
| 05/23/2006 | US7049455 Process for producing shogaols and intermediates for the synthesis thereof |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049339 comprises zinc sulphate, copper sulphate, an organic acid, an alkali metal salt; more effective at applying an active ingredient to a hoof than a conventional, non-colloid system; treatment of digital dermatitis |
| 05/23/2006 | US7049335 3-azabicyclo[3.1.0]hexane derivatives |
| 05/23/2006 | US7049331 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049315 Solubilized topoisomerase poisons |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049300 C-glycoside compounds for stimulating the synthesis of glycosaminoglycans |
| 05/23/2006 | US7049294 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 05/23/2006 | US7049119 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2006 | US7048943 Carotenoid-loaded liposomes |
| 05/23/2006 | US7048933 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | CA2319920C A cosmetic composition having at least one silicone/acrylate copolymer and at least one thickening agent |
| 05/23/2006 | CA2259550C Cosmetic or dermatological compound containing at least one natural, recombinant or analogous arachnid silk protein |
| 05/23/2006 | CA2245206C Use of an inhibitor of excitatory amino acids in a cosmetic or dermatological compound for sensitive skin, and the compound thus obtained |
| 05/23/2006 | CA2087591C Pyrimidine-3-oxide used for reducing hair loss; topical compositions used therefor |
| 05/18/2006 | WO2006053109A1 Heteroaryl compounds |
| 05/18/2006 | WO2006052515A1 Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone and hydroxydiphenyl ether |
| 05/18/2006 | WO2006052026A1 Acid salt of benzimidazole derivative and crystal thereof |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051818A1 Drug for external use and adhesive patch |
| 05/18/2006 | WO2006051410A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | WO2006050946A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors |
| 05/18/2006 | WO2006050816A1 Anti-demodicosis agent |
| 05/18/2006 | WO2006050734A2 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 05/18/2006 | WO2006050730A1 Novel salts of fumaric acid monoalkylesters and their pharmaceutical use |
| 05/18/2006 | WO2006009417A8 Method of obtaining total fixed lipids from seeds of the sapodilla family, for the preparation of cosmetics and dermatological pharmaceutical compositions |
| 05/18/2006 | WO2005092347A3 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle |
| 05/18/2006 | US20060106222 Aminoadamantane derivatives as therapeutic agents |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106206 plant extracts is produced from solvent extraction, contains a triglucose-picene structure compounds; as antiinflammatory agents treating autoimmune disease, cosmetic composition for prevent aging, and other skin disorders |
| 05/18/2006 | US20060106108 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060106075 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/18/2006 | US20060106072 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
| 05/18/2006 | US20060106048 Furoisoquinoline derivative and use thereof |
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060106003 Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease |
| 05/18/2006 | US20060105988 Antipruritic composition for external use on skin |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105430 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |
| 05/18/2006 | US20060105059 Fruit and/or vegetable derived composition |
| 05/18/2006 | US20060105046 Polymer conjugates of opioid antagonists |
| 05/18/2006 | US20060104998 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/18/2006 | US20060104947 Remedy for pemphigoid |
| 05/18/2006 | US20060104927 Plant extracts; antioxidant ; stability; whitening agent ; foods, cosmetics |
| 05/18/2006 | US20060104926 Whitening agent, skin preparation for external use and cosmetic |
| 05/18/2006 | US20060104925 Particle comprising a host lattice and a guest, its preparation and use in ultraviolet light screening compositions |
| 05/18/2006 | DE10156794B4 Arzneimittel zur Behandlung von Warzen Medicines used to treat warts |
| 05/18/2006 | CA2801903A1 Topical compositions comprising myrica gale oil |
| 05/18/2006 | CA2587173A1 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 05/18/2006 | CA2585660A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors |
| 05/17/2006 | EP1657954A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 05/17/2006 | EP1657242A1 Imidazopyridine derivatives |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1657233A1 Lipoxin compounds |
| 05/17/2006 | EP1656946A1 Tissue adhesive using synthetic crosslinking |
| 05/17/2006 | EP1656936A1 Macrophage activation inhibitor |
| 05/17/2006 | EP1656935A1 Use of physiologically active fatty acids for the treatment of pruritus |
| 05/17/2006 | EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/17/2006 | EP1656364A1 Chromen-4-one derivatives |
| 05/17/2006 | EP1656135A1 Method and composition for treating burned skin |
| 05/17/2006 | EP1656128A1 Treatment for acne vulgaris and method of use |
| 05/17/2006 | EP1656123A2 Anti-candida agents for the treatment of prion diseases |
| 05/17/2006 | EP1656100A1 Topical skin preparations for treatment of skin aging comprising a testosterone ester |
| 05/17/2006 | EP1543003B1 Imidazo¬1,2-a|pyridines |
| 05/17/2006 | EP1387660A4 Use of 3-position cyclosporin derivatives for hair growth |
| 05/17/2006 | EP1362047B1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 05/17/2006 | EP1349864B1 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1265616B1 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 05/17/2006 | EP1246810B1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials |
| 05/17/2006 | EP1229894B1 Cosmetic compositions containing chick pea extract and retinoids |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | CN2780196Y Plaster for removing scar |
| 05/17/2006 | CN1774448A Growth factor complexes and modulation of cell migration and growth |
| 05/17/2006 | CN1774257A Method for preparing a centella asiatica extracts rich in madecassoside and in terminoloside |
| 05/17/2006 | CN1772754A Synthesis process of cefpirome and its analog |
| 05/17/2006 | CN1772312A Wound dressing for first aid |
| 05/17/2006 | CN1772288A Recipe of skin repairing composition |